Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Other Accumulated Expenses: 2021

Historic Other Accumulated Expenses for Autolus Therapeutics (AUTL) over the last 1 years, with Dec 2021 value amounting to $1.5 million.

  • Autolus Therapeutics' Other Accumulated Expenses was N/A to $1.4 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2021, which is N/A change from last year.
  • As of FY2021, Autolus Therapeutics' Other Accumulated Expenses stood at $1.5 million.
  • Autolus Therapeutics' Other Accumulated Expenses' 5-year high stood at $1.5 million during FY2021, with a 5-year trough of $1.5 million in FY2021.
  • Moreover, its 1-year median value for Other Accumulated Expenses was $1.5 million (2021), whereas its average is $1.5 million.